A Survey of the Current Use of Neuromuscular Blocking Drugs Among the Middle Eastern Anesthesiologists

Overview

Journal Saudi J Anaesth

Specialty Anesthesiology

Date 2013 Aug 20

PMID 23956713

Citations 4

Authors

Abdelazeem Eldawlatly

Mohamed R El-Tahan

Affiliations

Soon will be listed here.

Abstract

Background: This survey aimed to assess the extent of practice of the Middle Eastern anesthesiologists in the use of neuromuscular blocking agents (NMB) in 2012.

Methods: We distributed an electronic survey among 577 members of the Triple-M Middle Eastern Yahoo anesthesia group, enquiring about their practice in the use of neuromuscular blocking agents. Questions concerned the routine first choice use of NMB, choice for tracheal intubation, the use of neuromuscular monitoring (NMT), type of NMB used in difficult airway, frequency of using suxamethonium, cisatracurium, rocuronium and sugammadex, observed side effects of rocuronium, residual curarization, and the reversal of residual curarization of rocuronium.

Results: A total of 71 responses from 22 Middle Eastern institutions were collected. Most of the Middle Eastern anesthesiologists were using cisatracurium and rocuronium frequently for tracheal intubation (39% and 35%, respectively). From the respondents, 2/3 were using suxamethonium for tracheal intubation in difficult airway, 1/3 were using rocuronium routinely and 17% have observed hypersensitivity reactions to rocuronium, 54% reported residual curarization from rocuronium, 78% were routinely using neostigmine to reverse the rocuronium, 21% used sugammadex occasionally, and 35% were using NMT routinely during the use of NMB.

Conclusions: We believe that more could be done to increase the awareness of the Middle Eastern anesthesiologists about the high incidence of PROC (>20%) and the need for routine monitoring of neuromuscular function. This could be accomplished with by developing formal training programs and providing official guidelines.

Citing Articles

[Management of neuromuscular block during general anesthesia : Results of a survey in Germany in 2020 compared to the recommendations of the first European guidelines in 2023].

Soukup J, Menzel F, Bucher M, Menzel M Anaesthesiologie. 2025; .

PMID: 40042592 DOI: 10.1007/s00101-025-01511-y.

REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study).

Greco M, Caruso P, Angelotti G, Aceto R, Coppalini G, Martinetti N J Clin Med. 2023; 12(2).

PMID: 36675492 PMC: 9866312. DOI: 10.3390/jcm12020563.

Cyclodextrins: Emerging Medicines of the New Millennium.

Braga S Biomolecules. 2019; 9(12).

PMID: 31795222 PMC: 6995511. DOI: 10.3390/biom9120801.

Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: a single-center retrospective study.

Park E, Lim B, Lee W, Lee I BMC Anesthesiol. 2016; 16(1):48.

PMID: 27484887 PMC: 4970270. DOI: 10.1186/s12871-016-0221-2.

Neuromuscular transmission monitoring: Beyond the electric shocks and the shaking hands.

Abdulatif M Saudi J Anaesth. 2013; 7(2):115-7.

PMID: 23956706 PMC: 3737682. DOI: 10.4103/1658-354X.114045.

References

Esteves S, Martins M, Barros F, Barros F, Canas M, Vitor P . Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal. Eur J Anaesthesiol. 2013; 30(5):243-9. DOI: 10.1097/EJA.0b013e32835dccd7. View

Nava-Ocampo A, Garduno-Espinosa J, Salmeron J . Preferences of Mexican anesthesiologists for vecuronium, rocuronium, or other neuromuscular blocking agents: a survey. BMC Anesthesiol. 2002; 2(1):2. PMC: 113756. DOI: 10.1186/1471-2253-2-2. View

McTernan C, Rapeport D, Ledowski T . Successful use of rocuronium and sugammadex in an anticipated difficult airway scenario. Anaesth Intensive Care. 2010; 38(2):390-2. DOI: 10.1177/0310057X1003800226. View

de Almeida M, Pederneiras S, Chiaroni S, de Souza L, Locks G . [Evaluation of tracheal intubation conditions in morbidly obese patients: a comparison of succinylcholine and rocuronium]. Rev Esp Anestesiol Reanim. 2009; 56(1):3-8. DOI: 10.1016/s0034-9356(09)70313-5. View

Docker D, Walther A . [Muscle relaxants and neuromuscular monitoring - Introduction for a safe clinical application]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2012; 47(5):296-305. DOI: 10.1055/s-0032-1313567. View

Kageyama K, Hayakawa Y, Nakajima Y, Hashimoto S . [Anaphylaxis during anesthesia--especially from neuromuscular blocking agents]. Masui. 2011; 60(1):55-66. View

Brereton A, Russell W . Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital. Anaesth Intensive Care. 2012; 40(5):861-6. DOI: 10.1177/0310057X1204000515. View

Della Rocca G, Iannuccelli F, Pompei L, Pietropaoli P, Reale C, Di Marco P . Neuromuscular block in Italy: a survey of current management. Minerva Anestesiol. 2012; 78(7):767-73. View

Whitaker Chair D, Booth H, Clyburn P, Harrop-Griffiths W, Hosie H, Kilvington B . Immediate post-anaesthesia recovery 2013: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2013; 68(3):288-97. DOI: 10.1111/anae.12146. View

10.

Duvaldestin P, Plaud B . Sugammadex in anesthesia practice. Expert Opin Pharmacother. 2010; 11(16):2759-71. DOI: 10.1517/14656566.2010.528391. View

11.

Fuchs-Buder T, Hofmockel R, Geldner G, Diefenbach C, Ulm K, Blobner M . [The use of neuromuscular monitoring in Germany]. Anaesthesist. 2003; 52(6):522-6. DOI: 10.1007/s00101-003-0508-9. View

12.

Fink H, Hollmann M . Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade. Minerva Anestesiol. 2012; 78(4):473-82. View

13.

Fink H, Geldner G, Fuchs-Buder T, Hofmockel R, Ulm K, Wallek B . [Muscle relaxants in Germany 2005: a comparison of application customs in hospitals and private practices]. Anaesthesist. 2006; 55(6):668-78. DOI: 10.1007/s00101-006-1015-6. View

14.

Murphy G . Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol. 2006; 72(3):97-109. View

15.

Grayling M, Sweeney B . Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007; 62(8):806-9. DOI: 10.1111/j.1365-2044.2007.05101.x. View

16.

Naguib M, Kopman A, Lien C, Hunter J, Lopez A, Brull S . A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg. 2009; 111(1):110-9. DOI: 10.1213/ANE.0b013e3181c07428. View

17.

Geldner G, Fuchs-Buder T, Hofmockel R, Diefenbach C, Ulm K, Blobner M . [The use of muscle relaxants for routine induction of anesthesia in Germany]. Anaesthesist. 2003; 52(5):435-41. DOI: 10.1007/s00101-003-0494-y. View

18.

Sorgenfrei I, Viby-Mogensen J, Swiatek F . [Does evidence lead to a change in clinical practice? Danish anaesthetists' and nurse anesthetists' clinical practice and knowledge of postoperative residual curarization]. Ugeskr Laeger. 2005; 167(41):3878-82. View

19.

Sorensen M, Bretlau C, Gatke M, Sorensen A, Rasmussen L . Rapid sequence induction and intubation with rocuronium-sugammadex compared with succinylcholine: a randomized trial. Br J Anaesth. 2012; 108(4):682-9. DOI: 10.1093/bja/aer503. View